Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
0.4813
-0.0351 (-6.80%)
At close: May 22, 2026, 4:00 PM EDT
0.4670
-0.0143 (-2.97%)
After-hours: May 22, 2026, 7:59 PM EDT

Sunshine Biopharma Revenue

Sunshine Biopharma had revenue of $8.09M in the quarter ending March 31, 2026, a decrease of -9.13%. This brings the company's revenue in the last twelve months to $35.49M, down -2.05% year-over-year. In the year 2025, Sunshine Biopharma had annual revenue of $36.31M with 4.11% growth.

Revenue (ttm)
$35.49M
Revenue Growth
-2.05%
P/S Ratio
0.07
Revenue / Employee
$709,866
Employees
50
Market Cap
2.36M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202536.31M1.43M4.11%
Dec 31, 202434.87M10.78M44.75%
Dec 31, 202324.09M19.75M454.42%
Dec 31, 20224.35M4.12M1,802.41%
Dec 31, 2021228.43K157.02K219.88%
Dec 31, 202071.41K50.29K238.10%
Dec 31, 201921.12K--
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 20151.71K--
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Jul 31, 2009---
Jul 31, 2008---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition